SSKN · CIK 0001051514 · operating
STRATA Skin Sciences is a medical technology company that develops and commercializes dermatological treatment devices for conditions including psoriasis, vitiligo, and acne. The company's primary product portfolio consists of the XTRAC excimer laser and VTRAC lamp systems, which deliver targeted light therapy for various skin disorders, and the TheraClear acne therapy system designed to treat mild to moderate inflammatory and comedonal acne. These devices are used in dermatology clinics and group practices across multiple regions.
The company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment, reflecting both consumable and capital equipment revenue streams. STRATA serves dermatologists and dermatological group clinics as its primary customer base.
Based in Horsham, Pennsylvania, the company maintains a presence across the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The organization has 106 full-time employees. STRATA Skin Sciences was incorporated in Delaware in 1989 and was formerly known as MELA Sciences, Inc. until rebranding in January 2016. The company is traded on the OTC market.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-2.65 | $-2.65 | -754.8% | |
| 2023 | $-0.31 | $-0.31 | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — | |
| 2020 | $-0.13 | $-0.13 | -18.2% | |
| 2019 | $-0.11 | $-0.11 | +26.7% | |
| 2018 | $-0.15 | $-0.15 | +94.7% | |
| 2017 | $-2.85 | $-2.85 | -280.0% | |
| 2016 | $-0.75 | $-0.31 | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-28 | 0001140361-25-010772 | SEC ↗ |
| 2023-12-31 | 2024-03-28 | 0001140361-24-015754 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001140361-23-015429 | SEC ↗ |
| 2021-12-31 | 2022-03-21 | 0001140361-22-010347 | SEC ↗ |
| 2020-12-31 | 2021-03-25 | 0001051514-21-000018 | SEC ↗ |
| 2019-12-31 | 2020-03-17 | 0001051514-20-000015 | SEC ↗ |
| 2018-12-31 | 2019-10-30 | 0001051514-19-000084 | SEC ↗ |
| 2017-12-31 | 2018-04-02 | 0001051514-18-000012 | SEC ↗ |
| 2016-12-31 | 2017-03-13 | 0001051514-17-000014 | SEC ↗ |
| 2015-12-31 | 2016-03-15 | 0001051514-16-000048 | SEC ↗ |
| 2014-12-31 | 2015-03-30 | 0001615774-15-000575 | SEC ↗ |
| 2013-12-31 | 2014-03-17 | 0001193125-14-102619 | SEC ↗ |
| 2012-12-31 | 2013-03-05 | 0001193125-13-091842 | SEC ↗ |
| 2011-12-31 | 2012-03-09 | 0001193125-12-106195 | SEC ↗ |
| 2010-12-31 | 2011-03-03 | 0000950123-11-021697 | SEC ↗ |
| 2009-12-31 | 2010-03-04 | 0000950123-10-020941 | SEC ↗ |
| 2008-12-31 | 2009-03-02 | 0000950123-09-003799 | SEC ↗ |
| 2007-12-31 | 2008-03-12 | 0000950123-08-002847 | SEC ↗ |
| 2006-12-31 | 2007-03-15 | 0000950123-07-003922 | SEC ↗ |
| 2005-12-31 | 2006-03-29 | 0000950123-06-003863 | SEC ↗ |